# MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors

> **NCT02444884** · PHASE1 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 54 (actual)

## Conditions studied

- Unspecified Childhood Solid Tumor, Excluding CNS
- Neuroblastoma

## Interventions

- **DRUG:** MLN8237

## Key facts

- **NCT ID:** NCT02444884
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02444884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02444884, "MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02444884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*